12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok

Hoelzer D, Ludwig W-D, , Thiel E et al (1996) Improved outcome in adult B-cell acute lymphoblastic leukaemia.
Blood, 87, 495-508.
Magrath I, Adde M, Shad A et al (1996). Adults and children with small non-cleaved lymphoma have a similar
excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol ,14,925-935.
Thomas D, Cortes J, O’ Brien S, et al ( 1999 ). Hyper-CVAD program in Burkitts type adult acute lymphoblastic
leukaemia. J Clin Oncol, 17, 2461-2470.
Thomas DA, Faderl S, O’Brien et al (2006). Chemoimmunotherapy with hyper-CVAD plus rituximab for the
treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukaemia. Cancer, 106, 1569-1580
Autolog transplantation
Sweetenham J, Pearce R, Taghipour G, Blaise D, et al (1996). Adult Burkitt’s and Burkitt-like non-Hodgkin’s
lymphoma: outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first
remission or at relapse: results from the European Group for Blood and Marrow Transplantation. J Clin Oncol,
14,2465-2472.
Nademanee A, Molina A, O'Donnell MR et al (1997). Results of high-dose therapy and autologous bonemarrow/stem-cell
transplantation during remission in poor-rsik intermediate and high-grade lymphoma:
International Index high and high-intermediate group. Blood, 90,3844-3852.
Smeland S, Blystad AK, Kvaloy SO, Ikonomou IM et al (2004). Treatment of Burkitt’s/Burkitt-like lymphoma in
adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three
successive regimens. Ann Oncol, 15, 1072-1078.
Allogen transplantation
Peniket AJ, Ruiz de Elvira MC, Taghipour G, Cordonnier C et al (2003). An EBMT registry matched study of
allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relaps rate
but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplant., 31, 667-
678.
65